Koers NH Special Purpose Acqtn 2Nd Co Ltd Korea S.E.
Aandelen
Geavanceerde medische apparatuur & technologie
slotkoers
Andere beurzen
|
||
- | - |
Omzet 2024 * | 159 mld. 114 mln. 0 107 mln. | Omzet 2025 * | 174 mld. 125 mln. 0 117 mln. | Marktkapitalisatie | 354 mld. 254 mln. 0 238 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 37 mld. 26,57 mln. - 24,94 mln. | Nettowinst (verlies) 2025 * | 38 mld. 27,28 mln. - 25,61 mln. | EV/omzet 2024 * | 1,61 x |
Nettoliquiditeiten 2024 * | 98,3 mld. 70,58 mln. 0 66,25 mln. | Nettoliquiditeiten 2025 * | 128 mld. 91,69 mln. 0 86,07 mln. | EV/omzet 2025 * | 1,3 x |
K/w-verhouding 2024 * |
10,2
x | K/w-verhouding 2025 * |
9,78
x | Werknemers | - |
Dividendrendement 2024 * |
1,24% | Dividendrendement 2025 * |
1,09% | Vrij verhandelbaar | 59,1% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ui-Yeol Choe
CEO | Chief Executive Officer | 63 | 01-01-98 |
Ki-Bong Nam
CTO | Chief Tech/Sci/R&D Officer | 68 | 01-01-09 |
Yong-Hwan Byeon
BRD | Director/Board Member | 69 | 28-07-15 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ui-Yeol Choe
CEO | Chief Executive Officer | 63 | 01-01-98 |
Kang-Oh Kim
BRD | Director/Board Member | 51 | 01-01-17 |
Ki-Bong Nam
CTO | Chief Tech/Sci/R&D Officer | 68 | 01-01-09 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-54,19% | 2,2 mld. | |
+19,59% | 1,83 mld. | |
-8,65% | 1,42 mld. | |
+17,35% | 1,18 mld. | |
-24,23% | 864 mln. | |
+1,25% | 784 mln. | |
-34,22% | 723 mln. | |
-29,46% | 590 mln. | |
+16,98% | 575 mln. |